NCT01489826View on ClinicalTrials.gov

A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Solid Tumour
Interventions
DRUG

Dexanabinol

Patients will (initially) be given a slow intravenous (i.v.) infusion of Dexanabinol over 3 hours on Days 1, 8 and 15 of a three weekly (21 day) cycle.

OTHER

Cremophor

Drug vehicle.

Trial Locations (3)

LS9 7TF

Leeds Cancer Centre at St. James's University Hospital, Leeds

NE7 7DN

Northern Centre for Cancer Care, Freeman Hospital, Newcastle-upon-Tyne, UK, Newcastle upon Tyne

G12 0YN

The Beatson West of Scotland Cancer Centre,, Glasgow

All Listed Sponsors
lead

e-Therapeutics PLC

INDUSTRY

NCT01489826 - A Phase 1 Study of Dexanabinol in Patients With Advanced Solid Tumours | Biotech Hunter | Biotech Hunter